The Peer Support Study
Neuromuscular Diseases
About this trial
This is an interventional health services research trial for Neuromuscular Diseases
Eligibility Criteria
Eligibility Criteria for Peer-Support Program:
Inclusion Criteria
- score of <10 on the Centre for Epidemiological Studies Short Depression (CESSD) scale during recruitment screening or score of ≥ 10 with referral to psychiatry/ social work with≥ 1 session completed and ongoing monitoring19 (score of ≥10 is cutoff for positive depression screen);
- FC of individual with NMD using HMV followed at 1 of the 8 HMV programs;
- speaks and reads English;
- currently using the aTouchAway™ App (Aetonix, Ottawa, Canada) in the LIVE program.
Exclusion Criteria:
We will exclude those Ventilator Assisted Individuals (VAI) and caregivers, who are:
(1) Unable to communicate verbally in English
Eligibility Criteria for Peer Mentors:
Inclusion Criteria:
- score of <10 on the Centre for Epidemiological Studies Short Depression (CESSD) scale;
- criteria 2-4 above;
- FC of an individual using HMV for ≥ 5 years;
- completion of virtual peer support training;
- identified by the HMV team or self-referral.
Exclusion Criteria:
We will exclude those VAIs and caregivers, who are:
(1) Unable to communicate verballyin English
Sites / Locations
- The Hospital for Sick ChildrenRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Intervention
Control
After informed consent, we will assign participants in a 1:1 ratio to the intervention or control group using Randomize.net. Participants randomized to intervention group will get access to the Virtual Peer Support Program.
Control group: Those randomized to the waitlist control will be given access to the peer support intervention on completion of the first 12-week program. A waitlist control group is an ethical alternative to no-treatment control groups when studying psychological and behavioral interventions 21. will have access to informational resources via the aTouchAway™ App and will also receive the intervention at the end of the trial.